Imagine spending thousands of dollars on weight-loss medication—only to discover months later that it doesn't work for your ...

Studies show that 1 in 3 American adults has prediabetes - but 8 in 10 of them don't know it. For the millions of Americans with undetected prediabetes or early metabolic dysfunction, accessible ...

Hims & Hers Health (NYSE:HIMS) has launched Labs AI, an AI care agent that provides users with personalized, clinically vetted interpretations of their lab results. The company is also expanding into ...

For the past three years, nearly every breakthrough in obesity medicine has traced back to a single class of drugs: GLP-1 receptor agonists like semaglutide and tirzepatide. Now, a phase 2 clinical ...

Biochemist Svetlana Mojsov, PhD, has been awarded the Frontiers of Knowledge Award in Biology and Biomedicine, presented by Spain’s BBVA Foundation, for her collaborative research with Daniel Drucker, ...

Samsung and Mass General are studying whether Galaxy Watch8 data can help doctors monitor muscle loss during GLP-1 ...

GLP-1 medications aid weight loss, but experts emphasise supervised care, diagnostics, nutrition, and lifestyle changes for ...

NEW YORK--(BUSINESS WIRE)--Nourish, the leading metabolic health provider powered by the largest dietitian network in the country, today announced the launch of Nourish Labs, a new program that gives ...

A study has found that glucagon-like peptide-1 receptor agonist use was associated with lower all-cause mortality and reduced ...